Delphinus is one of “14 Innovative High-Tech Companies Revitalizing Detroit”
Founded in 2010, Delphinus Medical Technologies is a spin-off subsidiary of the Barbara Ann Karmanos Cancer Institute and is located in Plymouth. The privately held medical technology company, led by president and CEO Mark Forchette, has developed an ultrasound breast cancer detection device called SoftVueTM. It uses sound speed transmission information, reflection and attenuation as the basis of its imaging, which can be used for diagnostic applications.
Read the original blog post here.